Theravance Biopharma Target Price

Explore Theravance Biopharma's target price with historical charts and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Share Price

$17.03

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-07-07	H.C. Wainwright	$17	0.2% downside
2026-03-04	B.Riley FinancialMayank Mamtani	$14	17.8% downside
2025-12-03	Oppenheimer	$27	58.5% upside
2025-11-26	BTIG	$40	134.9% upside
2024-11-13	Leerink PartnersDavid Risinger	$10	41.3% downside
2024-08-06	H.C. WainwrightDouglas Tsao	$15	11.9% downside
2024-04-12	BTIGJulian Harrison	$21	23.3% upside
2022-11-17	Leerink Partners	$14	17.8% downside

Theravance Biopharma (TBPH) FAQ

Stockcircle tracks target price for Theravance Biopharma (TBPH), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Theravance Biopharma's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main TBPH overview so you can move from this figure to the surrounding analysis quickly.